News
Ocular Therapeutix’ investigational therapy, AXPAXLI™ (also known as OTX-TKI), is an axitinib hydrogel administered by intravitreal injection that has the potential to dramatically improve durability ...
AUSTIN, TX / ACCESS Newswire / June 25, 2025 / In 2025, your logo doesn’t represent the brand. Your face does. Consumers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback